Epigallocatechin gallate
Epigallocatechin gallate (EGCG) is a major catechin polyphenol found in tea and is widely studied as a bioactive natural product with antioxidant, anti-inflammatory, and putative anticancer properties.
Epigallocatechin gallate (EGCG) is a major catechin polyphenol found in tea and is widely studied as a bioactive natural product with antioxidant, anti-inflammatory, and putative anticancer properties. In biomedical research, it is often investigated as a small-molecule modulator of signaling pathways, protein-ligand interactions, and oxidative stress responses rather than as a conventional drug.
Recent studies continue to position EGCG as a versatile research compound with relevance to inflammation, infection-resistant biomaterials, reproductive biology, and cancer-oriented delivery systems. Its reported interactions with targets such as RORγ, and its incorporation into nanoparticle, liposomal, and scaffold-based platforms, reflect ongoing efforts to improve its stability, tissue delivery, and therapeutic utility.
Where the papers sit
25 papers from the last 6 months study epigallocatechin gallate directly · updated from PubMed 16 Nov 2026
Study type 0 clinical trials · 24 preclinical · 1 unclassified
Themes one subject · 1 new direction
Those 25 are all about one subject.
-
EGCG Therapeutic Applications
EGCG research is moving toward targeted delivery and combination treatment across cancer, inflammatory disease, infection, tissue injury, and metabolic disorders. Nanoparticles, hydrogels, liposomes, microneedles, and colon- or kidney-directed systems recur as strategies to improve stability and tissue exposure. NF-κB suppression, ROS control, immune remodeling, angiogenesis inhibition, and reversal of treatment resistance are recurring biological themes. Evidence remains preclinical and broad, without a single dominant disease or mechanism.
EGCG is presented as a trigger of BAT-independent thermogenesis in obesity
The obesity model in high-fat-diet-induced obese mice treated with EGCG assumed the compound could counter obesity through its established anti-obesity and immunometabolic effects, but instead reported a BAT-independent thermogenic switch alongside remodeling of the immune microenvironment in subcutaneous adipose tissue. This gives EGCG a role as a direct inducer of energy expenditure that does not depend on brown adipose tissue activity, extending its use beyond the anticancer, anti-inflammatory, antioxidant, antimicrobial, and delivery-system roles represented elsewhere in the set 42607554Aug.
Papers
The 25 papers from the last 6 months that study epigallocatechin gallate directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
EGCG Therapeutic Applications (25)
- Multi-omics and pharmacological analyses identify DDX60 as a candidate EGCG-engaged target in esophageal squamous cell carcinoma. European journal of pharmacology · 12 Nov 2026 PMID 43020306
- Shape-memory scaffold targets inflammation and fibrosis to restore endometrium and fertility in intrauterine adhesions. Science advances · 6 Nov 2026 PMID 42993828
- Spatiotemporal bilayer microneedle patches enable bacterial control and ROS-driven immunomodulation for infected wound healing. Journal of materials chemistry. B · 19 Oct 2026 PMID 42895083
- Epigallocatechin gallate overcomes oxaliplatin resistance in colorectal cancer by suppressing NF-κB signaling and disrupting mitochondrial homeostasis. Bioorganic chemistry · 8 Oct 2026 PMID 42849137
- Epigallocatechin-3-Gallate, the green tea polyphenol suppresses expression of CD31 and VEGFR2 and enhances the chemotherapeutic potential of irinotecan in AOM/DSS model of colorectal cancer in mice. Journal of the Egyptian National Cancer Institute · 17 Sept 2026 PMID 42752748
- Colon-targeted EGCG delivery remodels the gut microenvironment to enhance therapeutic efficacy in ulcerative colitis. Journal of controlled release : official journal of the Controlled Release Society · 16 Sept 2026 PMID 42749134
- An integrative computational and experimental evaluation of natural compounds with potential to target LuxS in Klebsiella pneumoniae. Archives of microbiology · 15 Sept 2026 PMID 42742729
- Harnessing (-)-epigallocatechin-3-gallate (EGCG) with chitosan-coated liposomes to modulate the radiation effect in cancer cells through alteration in the miR-139-5p-β-catenin axis. Biomaterials science · 15 Sept 2026 PMID 42741861
- Albumin-Coated Mesoporous Polydopamine Nanoparticles for Renal Delivery of Epigallocatechin Gallate against Cisplatin-Induced Acute Kidney Injury. ACS applied materials & interfaces · 2 Sept 2026 PMID 42686388
- EGCG combats obesity by triggering a BAT-independent thermogenic switch and remodeling the immune microenvironment in subcutaneous adipose tissue. Phytomedicine : international journal of phytotherapy and phytopharmacology · 17 Aug 2026 PMID 42607554
- QbD-engineered EGCG-rosmarinic acid cubosomal hydrogel for controlled skin delivery and antimelanoma efficacy. International journal of pharmaceutics · 25 Jul 2026 PMID 42501769
- Activation of the NF-κB/ALDH1A1 signaling promotes non-mutational resistance to EGFR-TKIs in non-small cell lung cancer. Oncogene · 23 Jul 2026 PMID 42493544
- Multi-modular responsive hydroxypropyl chitosan-based hydrogel microspheres for stage-specific therapy in infected wounds. Carbohydrate polymers · 23 Jul 2026 PMID 42493128
- Solid nano-lipoidal intelligent premix (SNIP): designing, optimization, and characterization. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 22 Jul 2026 PMID 42484807
- Nanoparticle-Cross-Linked Smart Responsive Hydrogels for Antimicrobial, Anti-Inflammatory, and Antioxidant Treatment of Diabetic Wounds. Biomacromolecules · 21 Jul 2026 PMID 42479468
- Epigallocatechin gallate enhances panobinostat-induced cytotoxicity through HDAC modulation in colorectal cancer cells. Molecular biology reports · 15 Jul 2026 PMID 42455377
- Multicomponent Micelles with Boosted Stability of Iminoboronates. Biomacromolecules · 3 Jul 2026 PMID 42397949
- Epigallocatechin Gallate Attenuates Arecoline-induced Migration and Invasion in Esophageal Squamous Cell Carcinoma Cells Associated With EGFR/AKT/P38 Signaling. Anticancer research · 29 Jun 2026 PMID 42373249
- Polyphenol-based nanoparticles enhancing doxycycline efficacy for acne therapy. Journal of materials chemistry. B · 26 Jun 2026 PMID 42358218
- Kinetics of Lignin/Epigallocatechin Gallate Co-Release by Multiscale Structures of Dual-Dynamic Cross-Linked Hydrogels. Biomacromolecules · 19 Jun 2026 PMID 42319084
- Multi-mode ultrasonic-driven self-assembly of banana-derived resistant starch nanoparticles for epigallocatechin gallate encapsulation and in vitro antiglycation evaluation. International journal of biological macromolecules · 16 Jun 2026 PMID 42303019
- Self-assembled nanoparticles of epigallocatechin gallate and tannic acid against triple-negative breast cancer via mediating mitochondrial damage. Nanotechnology · 9 Jun 2026 PMID 42263713
- Structure-function analysis of sodium caseinate-gum arabic-EGCG ternary complexes prepared via ultrasound-assisted glycation. International journal of biological macromolecules · 4 Jun 2026 PMID 42242649
- Peanut protein-fortified alginate hydrogel beads for EGCG encapsulation: Fabrication, characterization, and in vitro digestive behavior. International journal of biological macromolecules · 3 Jun 2026 PMID 42235770
- Evaluation of antioxidant-enriched cream formulations and their clinical effects in mild to moderate atopic dermatitis. International journal of pharmaceutics · 1 Jun 2026 PMID 42225173
By study type
Preclinical: animal, cell and lab studies (24)
- Shape-memory scaffold targets inflammation and fibrosis to restore endometrium and fertility in intrauterine adhesions. Science advances · 6 Nov 2026 PMID 42993828
- Spatiotemporal bilayer microneedle patches enable bacterial control and ROS-driven immunomodulation for infected wound healing. Journal of materials chemistry. B · 19 Oct 2026 PMID 42895083
- Epigallocatechin gallate overcomes oxaliplatin resistance in colorectal cancer by suppressing NF-κB signaling and disrupting mitochondrial homeostasis. Bioorganic chemistry · 8 Oct 2026 PMID 42849137
- Epigallocatechin-3-Gallate, the green tea polyphenol suppresses expression of CD31 and VEGFR2 and enhances the chemotherapeutic potential of irinotecan in AOM/DSS model of colorectal cancer in mice. Journal of the Egyptian National Cancer Institute · 17 Sept 2026 PMID 42752748
- Colon-targeted EGCG delivery remodels the gut microenvironment to enhance therapeutic efficacy in ulcerative colitis. Journal of controlled release : official journal of the Controlled Release Society · 16 Sept 2026 PMID 42749134
- An integrative computational and experimental evaluation of natural compounds with potential to target LuxS in Klebsiella pneumoniae. Archives of microbiology · 15 Sept 2026 PMID 42742729
- Harnessing (-)-epigallocatechin-3-gallate (EGCG) with chitosan-coated liposomes to modulate the radiation effect in cancer cells through alteration in the miR-139-5p-β-catenin axis. Biomaterials science · 15 Sept 2026 PMID 42741861
- Albumin-Coated Mesoporous Polydopamine Nanoparticles for Renal Delivery of Epigallocatechin Gallate against Cisplatin-Induced Acute Kidney Injury. ACS applied materials & interfaces · 2 Sept 2026 PMID 42686388
- EGCG combats obesity by triggering a BAT-independent thermogenic switch and remodeling the immune microenvironment in subcutaneous adipose tissue. Phytomedicine : international journal of phytotherapy and phytopharmacology · 17 Aug 2026 PMID 42607554
- QbD-engineered EGCG-rosmarinic acid cubosomal hydrogel for controlled skin delivery and antimelanoma efficacy. International journal of pharmaceutics · 25 Jul 2026 PMID 42501769
- Activation of the NF-κB/ALDH1A1 signaling promotes non-mutational resistance to EGFR-TKIs in non-small cell lung cancer. Oncogene · 23 Jul 2026 PMID 42493544
- Multi-modular responsive hydroxypropyl chitosan-based hydrogel microspheres for stage-specific therapy in infected wounds. Carbohydrate polymers · 23 Jul 2026 PMID 42493128
- Solid nano-lipoidal intelligent premix (SNIP): designing, optimization, and characterization. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 22 Jul 2026 PMID 42484807
- Nanoparticle-Cross-Linked Smart Responsive Hydrogels for Antimicrobial, Anti-Inflammatory, and Antioxidant Treatment of Diabetic Wounds. Biomacromolecules · 21 Jul 2026 PMID 42479468
- Epigallocatechin gallate enhances panobinostat-induced cytotoxicity through HDAC modulation in colorectal cancer cells. Molecular biology reports · 15 Jul 2026 PMID 42455377
- Multicomponent Micelles with Boosted Stability of Iminoboronates. Biomacromolecules · 3 Jul 2026 PMID 42397949
- Epigallocatechin Gallate Attenuates Arecoline-induced Migration and Invasion in Esophageal Squamous Cell Carcinoma Cells Associated With EGFR/AKT/P38 Signaling. Anticancer research · 29 Jun 2026 PMID 42373249
- Polyphenol-based nanoparticles enhancing doxycycline efficacy for acne therapy. Journal of materials chemistry. B · 26 Jun 2026 PMID 42358218
- Kinetics of Lignin/Epigallocatechin Gallate Co-Release by Multiscale Structures of Dual-Dynamic Cross-Linked Hydrogels. Biomacromolecules · 19 Jun 2026 PMID 42319084
- Multi-mode ultrasonic-driven self-assembly of banana-derived resistant starch nanoparticles for epigallocatechin gallate encapsulation and in vitro antiglycation evaluation. International journal of biological macromolecules · 16 Jun 2026 PMID 42303019
- Self-assembled nanoparticles of epigallocatechin gallate and tannic acid against triple-negative breast cancer via mediating mitochondrial damage. Nanotechnology · 9 Jun 2026 PMID 42263713
- Structure-function analysis of sodium caseinate-gum arabic-EGCG ternary complexes prepared via ultrasound-assisted glycation. International journal of biological macromolecules · 4 Jun 2026 PMID 42242649
- Peanut protein-fortified alginate hydrogel beads for EGCG encapsulation: Fabrication, characterization, and in vitro digestive behavior. International journal of biological macromolecules · 3 Jun 2026 PMID 42235770
- Evaluation of antioxidant-enriched cream formulations and their clinical effects in mild to moderate atopic dermatitis. International journal of pharmaceutics · 1 Jun 2026 PMID 42225173
Unclassified: not yet indexed with MeSH (1)
- Multi-omics and pharmacological analyses identify DDX60 as a candidate EGCG-engaged target in esophageal squamous cell carcinoma. European journal of pharmacology · 12 Nov 2026 PMID 43020306
Written from 25 PubMed abstracts, each one listed by PMID above. Published: 2026-06-15. Last written: 2026-09-17 by GPT. Drafted by language models from published abstracts; not medical advice.